An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses.

Airway inflammation is often associated with bacterial infections and represents a major determinant of lung disease. The in vivo determination of the pro-inflammatory capabilities of various factors is challenging and requires terminal procedures, such as bronchoalveolar lavage and the removal of lungs for in situ analysis, precluding longitudinal visualization in the same mouse. Here, lung inflammation is induced through the intratracheal instillation of Pseudomonas aeruginosa culture supernatant (SN) in transiently transgenized mice expressing the luciferase reporter gene under the control of a heterologous IL-8 bovine promoter. Luciferase expression in the lung is monitored by in vivo bioluminescent image (BLI) analysis over a 2.5- to 48-h timeframe following the instillation. The procedure can be repeated multiple times within 2 - 3 months, thus permitting the evaluation of the inflammatory response in the same mice without the need to terminate the animals. This approach permits the monitoring of pro- and anti-inflammatory factors acting in the lung in real time and appears suitable for functional and pharmacological studies.

[1]  Jan Michiels,et al.  Molecular mechanisms and clinical implications of bacterial persistence. , 2016, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[2]  G. Donofrio,et al.  In vivo monitoring of lung inflammation in CFTR-deficient mice , 2016, Journal of Translational Medicine.

[3]  I. Adcock,et al.  Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease , 2016, Translational research : the journal of laboratory and clinical medicine.

[4]  P. Barnes Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. , 2015, The Journal of allergy and clinical immunology.

[5]  G. Donofrio,et al.  In vivo imaging of the lung inflammatory response to Pseudomonas aeruginosa and its modulation by azithromycin , 2015, Journal of Translational Medicine.

[6]  G. Rossi,et al.  Host Genetic Background Influences the Response to the Opportunistic Pseudomonas aeruginosa Infection Altering Cell-Mediated Immunity and Bacterial Replication , 2014, PloS one.

[7]  F. Huaux,et al.  Lung inflammation in cystic fibrosis: pathogenesis and novel therapies. , 2014, Clinical biochemistry.

[8]  P. Foster,et al.  Murine models of infectious exacerbations of airway inflammation. , 2013, Current opinion in pharmacology.

[9]  E. Kerem,et al.  Airway inflammation in cystic fibrosis: molecular mechanisms and clinical implications , 2013, Thorax.

[10]  A. Capocefalo,et al.  In Vivo Imaging of Transiently Transgenized Mice with a Bovine Interleukin 8 (CXCL8) Promoter/Luciferase Reporter Construct , 2012, PloS one.

[11]  S. Sagel Noninvasive biomarkers of airway inflammation in cystic fibrosis , 2003, Current opinion in pulmonary medicine.

[12]  D. Danilenko,et al.  Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. , 1994, The Journal of clinical investigation.

[13]  W. Wood,et al.  Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. , 1994, Science.